curcumin and Hepatorenal-Syndrome

curcumin has been researched along with Hepatorenal-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for curcumin and Hepatorenal-Syndrome

ArticleYear
Antioxidant and anti-inflammatory effects of curcumin against hepatorenal oxidative injury in an experimental sepsis model in rats.
    Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2013, Volume: 19, Issue:6

    To investigate the effects of curcumin, an antioxidant and anti-inflammatory agent, on free oxygen radicals and lipid peroxidation in an experimental sepsis model, as well as to determine the role of curcumin in preventing hepatorenal tissue damage caused by sepsis.. The rats were randomly divided into three groups (n=8) as follows: control group (group 1); sepsis group (group 2); and sepsis + curcumin group (group 3). Sepsis was created using the cecal ligation and perforation (CLP) method. Curcumin was administered intraperitoneally (200 mg/kg) in two equal doses just after the perforation and at twelve hours post-perforation.. Serum TNF-a and IL-1ß, and tissue MDA and MPO values were higher, whereas tissue GSH and Na+/K+-ATPase values were lower, in group 2 as compared to group 1. These values in group 3 were the inverse of those in group 2. As compared to group 1, histopathological evaluation of group 2 showed damaged hepatocytes, glomeruli, and tubules, whereas the damage was significantly reduced in group 3 as compared to group 2.. The strong antioxidant and anti-inflammatory effects of curcumin against potential hepatorenal damage were shown using an experimental sepsis model in rats.

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cecum; Curcumin; Disease Models, Animal; Free Radicals; Hepatorenal Syndrome; Injections, Intraperitoneal; Ligation; Lipid Peroxidation; Male; Random Allocation; Rats; Rats, Wistar; Sepsis; Tumor Necrosis Factor-alpha

2013